Gregory Tasian, MD, pediatric urologist at CHOP, discusses the rise of kidney stones with Dr. Max Gomez.

Systematic laboratory studies find some antioxidants should be tested in clinical trials as treatments for patients with mitochondrial disease.

Neurology researchers studying a rare, devastating condition in infants have discovered the cause: gene mutations that disrupt mitochondria in cells.

A recent article in Cardiovascular Business explored the pros and cons of congenital heart disease survivorship clinics across the country.

Find ideas for breaking from convention in school lunches and packing gluten-free food your child will love.

Children’s Hospital's Office of Entrepreneurship and Innovation empowers employees to find “a better way” and foster an entrepreneurial spirit.

New strategies in minimally-invasive heart surgeries are helping patients delay or even avoid open-heart surgery.

CHOP has found a long-suspected “missing mutation” in severe infant epilepsy, with early hints that anti-seizure drugs might help patients.

Proceeds from Cheers for CHOP supports the Division of Orthopaedics at Children's Hospital of Philadelphia (CHOP), one of the largest and most active pediatric orthopaedic centers in the world.

Children with mitochondrial diseases who suffered acute metabolic strokes benefited from rapid IV treatment with the amino acid arginine, with no side effects.